Substituted 16,17-annellated steroid compounds for use in women's healthcare

Details for Australian Patent Application No. 2010257474 (hide)

Owner N.V. Organon

Inventors Dijcks, Fredericus Antonius; Loozen, Hubert Jan Jozef; Addo, Samira; Ederveen, Antonius Gerardus Hendrikus

Agent Spruson & Ferguson

Pub. Number AU-A-2010257474

PCT Pub. Number WO2010/142705

Priority 09162437.9 10.06.09 EP

Filing date 9 June 2010

Wipo publication date 16 December 2010

International Classifications

C07J 53/00 (2006.01) Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by condensation with carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms

A61K 31/57 (2006.01) - substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone

A61P 5/30 (2006.01) Drugs for disorders of the endocrine system

A61P 5/32 (2006.01) Drugs for disorders of the endocrine system

A61P 5/34 (2006.01) Drugs for disorders of the endocrine system

A61P 5/36 (2006.01) Drugs for disorders of the endocrine system

Event Publications

12 January 2012 PCT application entered the National Phase

  PCT publication WO2010/142705 Priority application(s): WO2010/142705

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010257482-Risk markers for cardiovascular disease

2010257471-Continuous Culture Apparatus with Mobile Vessel, Allowing Selection of Filter Cell Variants